Chemplast Sanmar Limited (NSE:CHEMPLASTS)
| Market Cap | 27.14B -58.2% |
| Revenue (ttm) | 42.49B -1.2% |
| Net Income | -3.91B |
| EPS | -24.81 |
| Shares Out | 158.11M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 429,578 |
| Open | 178.70 |
| Previous Close | 178.57 |
| Day's Range | 170.02 - 180.74 |
| 52-Week Range | 170.41 - 460.80 |
| Beta | -0.11 |
| Analysts | Strong Buy |
| Price Target | 277.25 (+60.63%) |
| Earnings Date | Aug 6, 2026 |
About Chemplast Sanmar
Chemplast Sanmar Limited engages in manufacturing and selling of specialty chemicals in India. The company offers specialty paste PVC resins; custom manufactured chemicals, such as organic chemicals, and phyto chemicals comprising colchicine and thiocolchicoside; and hydrogen peroxide. It also provides caustic chlor products, including caustic soda lye and flakes, chlorine, hydrochloric acid, and hydrogen; refrigerant gas, that includes hydrochlorofluorocarbons under the Mettron brand name; and solvents comprising chloromethanes products, such ... [Read more]
Financial Performance
In fiscal year 2026, Chemplast Sanmar's revenue was 42.24 billion, a decrease of -2.81% compared to the previous year's 43.46 billion. Losses were -2.80 billion, 153.6% more than in 2025.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for CHEMPLASTS stock is "Strong Buy." The 12-month stock price target is ₹277.25, which is an increase of 60.63% from the latest price.
News
Chemplast Sanmar Transcript: Q1 26/27
Revenue declined sharply year-over-year due to high input costs, resulting in an EBITDA loss, but management expects profitability to improve from Q3 as market spreads normalize and new capacity ramps up. Specialty chemicals and CMCD segments showed resilience, with strong order books and ongoing diversification.
Chemplast Sanmar Quarterly report: Q1 2027
Chemplast Sanmar has published its Q1 2027 quarterly earnings report on August 7, 2026.
Chemplast Sanmar Slides: Q1 2027
Chemplast Sanmar has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 7, 2026.
Chemplast Sanmar Transcript: Q4 25/26
FY 2026 saw revenue growth but was marked by significant losses due to impairment and exceptional charges amid challenging market conditions, especially in Suspension PVC. Speciality segments showed resilience, and strategic reviews are underway to unlock value.
Chemplast Sanmar Quarterly report: Q4 2026
Chemplast Sanmar has published its Q4 2026 quarterly earnings report on May 26, 2026.
Chemplast Sanmar Slides: Q4 2026
Chemplast Sanmar has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 26, 2026.
Chemplast Sanmar Annual report: Q4 2026
Chemplast Sanmar has published its Q4 2026 annual report on May 26, 2026.
Chemplast Sanmar Transcript: Q3 25/26
Q3 FY26 saw a 21% revenue drop and a net loss of INR 119 crores amid regulatory and market headwinds. Suspension PVC and value-added chemicals faced significant pressure, but demand and prices are rebounding, with capacity expansions and regulatory changes expected to support recovery.
Chemplast Sanmar Quarterly report: Q3 2026
Chemplast Sanmar has published its Q3 2026 quarterly earnings report on February 9, 2026.
Chemplast Sanmar Slides: Q3 2026
Chemplast Sanmar has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 9, 2026.
Chemplast Sanmar Transcript: Q2 25/26
Q2 FY26 saw improved revenue and EBITDA, driven by higher PVC volumes, but profitability remains under pressure from low-priced imports and weak caustic soda prices. Ongoing capacity expansions and green initiatives are expected to support future growth, while high debt and regulatory uncertainties pose risks.
Chemplast Sanmar Quarterly report: Q2 2026
Chemplast Sanmar has published its Q2 2026 quarterly earnings report on November 14, 2025.
Chemplast Sanmar Slides: Q2 2026
Chemplast Sanmar has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 14, 2025.